MEDIORGPharmaceuticals
MEDICAMEN ORGANICS — Cash Flow Statement
₹21.10
+2.42%
MEDICAMEN ORGANICS Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | -4.03 Cr | -0.87 Cr | -0.58 Cr | -1.19 Cr |
| Issuance Of Capital Stock | 0.60 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -0.35 Cr | -0.29 Cr | -0.62 Cr | -0.03 Cr |
| End Cash Position | 0.43 Cr | 0.44 Cr | 0.37 Cr | 0.74 Cr |
| Beginning Cash Position | 0.44 Cr | 0.37 Cr | 0.74 Cr | 0.65 Cr |
| Changes In Cash | -74000.00 | 0.07 Cr | -0.37 Cr | 0.09 Cr |
| Financing Cash Flow | 4.01 Cr | 0.94 Cr | 0.18 Cr | 1.27 Cr |
| Net Other Financing Charges | 1.20 Cr | — | — | — |
| Interest Paid Cff | -0.65 Cr | -0.61 Cr | -0.47 Cr | -0.48 Cr |
| Net Common Stock Issuance | 0.60 Cr | 0.00 | 0.00 | — |
| Common Stock Issuance | 0.60 Cr | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 2.86 Cr | 1.55 Cr | 0.66 Cr | 1.75 Cr |
| Net Long Term Debt Issuance | 2.86 Cr | 1.55 Cr | 0.66 Cr | 1.75 Cr |
| Investing Cash Flow | -0.33 Cr | -0.28 Cr | -0.59 Cr | -0.02 Cr |
| Interest Received Cfi | 0.01 Cr | 81000.00 | 0.02 Cr | 0.01 Cr |
| Net PPE Purchase And Sale | -0.35 Cr | -0.29 Cr | -0.62 Cr | -0.03 Cr |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 3000.00 |
| Purchase Of PPE | -0.35 Cr | -0.29 Cr | -0.62 Cr | -0.03 Cr |
| Operating Cash Flow | -3.69 Cr | -0.58 Cr | 0.04 Cr | -1.16 Cr |
| Taxes Refund Paid | -0.21 Cr | -0.05 Cr | -0.07 Cr | -0.05 Cr |
| Change In Working Capital | -8.37 Cr | -2.43 Cr | -1.15 Cr | -3.18 Cr |
| Change In Other Current Liabilities | 0.03 Cr | 0.49 Cr | -0.47 Cr | 0.19 Cr |
| Change In Other Current Assets | 0.05 Cr | -0.05 Cr | -0.01 Cr | 0.04 Cr |
| Change In Payable | -1.92 Cr | 2.48 Cr | 0.48 Cr | -2.65 Cr |
| Change In Inventory | -36000.00 | -1.42 Cr | -2.06 Cr | 1.70 Cr |
| Change In Receivables | -6.52 Cr | -3.93 Cr | 0.91 Cr | -2.46 Cr |
| Other Non Cash Items | 0.65 Cr | -0.17 Cr | 0.28 Cr | 0.47 Cr |
| Depreciation And Amortization | 0.72 Cr | 0.71 Cr | 0.68 Cr | 0.68 Cr |
| Depreciation | 0.72 Cr | 0.71 Cr | 0.68 Cr | 0.68 Cr |
| Pension And Employee Benefit Expense | 0.03 Cr | -96000.00 | 0.04 Cr | 0.06 Cr |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 3.39 Cr | 1.36 Cr | 0.26 Cr | 0.49 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on MEDICAMEN ORGANICS
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.